Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Discovery of Anticancer Activity of Amentoflavone on Esophageal Squamous Cell Carcinoma: Bioinformatics, Structure-Based Virtual Screening, and Biological Evaluation

  • Chen, Lei (The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University) ;
  • Fang, Bo (College of Pharmacy, Wenzhou Medical University) ;
  • Qiao, Liman (The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University) ;
  • Zheng, Yihui (The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University)
  • Received : 2022.03.28
  • Accepted : 2022.04.28
  • Published : 2022.06.28
Download PDF
⟨ Previous Next ⟩

Abstract

Esophageal squamous cell carcinoma (ESCC) is the most common primary esophageal malignancy with poor prognosis. Here, due to the necessity for exploring potential therapies against ESCC, we obtained the gene expression data on ESCC from the TCGA and GEO databases. Venn diagram analysis was applied to identify common targets. The protein-protein interaction network was constructed by Cytoscape software, and the hub targets were extracted from the network via cytoHubba. The potential hub nodes as drug targets were found by pharmacophore-based virtual screening and molecular modeling, and the antitumor activity was evaluated through in vitro studies. A total of 364 differentially expressed genes (DEGs) in ESCC were identified. Pathway enrichment analyses suggested that most DEGs were mainly involved in the cell cycle. Three hub targets were retrieved, including CENPF, CCNA2 (cyclin A), and CCNB1 (cyclin B1), which were highly expressed in esophageal cancer and associated with prognosis. Moreover, amentoflavone, a promising drug candidate found by pharmacophore-based virtual screening, showed antiproliferative and proapoptotic effects and induced G1 in esophageal squamous carcinoma cells. Taken together, our findings suggested that amentoflavone could be a potential cell cycle inhibitor targeting cyclin B1, and is therefore expected to serve as a great therapeutic agent for treating esophageal squamous cell carcinoma.

Keywords

References

  1. Enzinger PC, Mayer RJ. 2013. Esophageal cancer. N. Engl. J. Med. 349: 2241-2252. https://doi.org/10.1056/NEJMra035010
  2. Jiang S, Zhang Q, Su Y, Pan L. 2018. Network-based differential analysis to identify molecular features of tumorigenesis for esophageal squamous carcinoma. Molecules 23: 88. https://doi.org/10.3390/molecules23010088
  3. Fukushima A, Kuroha T, Nagai K, Hattori Y, Kobayashi M, Nishizawa T, et al. 2020. Metabolite and phytohormone profiling illustrates metabolic reprogramming as an escape strategy of deepwater rice during partially submerged stress. Metabolites 10: 68. https://doi.org/10.3390/metabo10020068
  4. Wu Y, Zhu Y, Li S, Zeng M, Chu J, Hu P et al. 2017. Terrein performs antitumor functions on esophageal cancer cells by inhibiting cell proliferation and synergistic interaction with cisplatin. Oncol. Lett. 13: 2805-2810. https://doi.org/10.3892/ol.2017.5758
  5. Huang X, Rong H, Lin P, Wu Q, Yao G, Hou J et al. 2006. Cyclin D1 overexpression in esophageal cancer from southern China and its clinical significance. Cancer Lett. 231: 94-101. https://doi.org/10.1016/j.canlet.2005.01.040
  6. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. 2013. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 41: D991-995. https://doi.org/10.1093/nar/gks1193
  7. Edgar R, Domrachev M, Lash AE. 2002. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207-210. https://doi.org/10.1093/nar/30.1.207
  8. Chen YK, Tung CW, Lee JY, Hung YC, Lee CH, Chou SH, et al. 2016. Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma. Sci. Rep. 6: 30057. https://doi.org/10.1038/srep30057
  9. Wen J, Yang H, Liu MZ, Luo KJ, Liu H, Hu Y, et al. 2014. Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy. Ann. Oncol. 25: 1769-1774. https://doi.org/10.1093/annonc/mdu201
  10. Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. 2019. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47: D607-d613. https://doi.org/10.1093/nar/gky1131
  11. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13: 2498-2504. https://doi.org/10.1101/gr.1239303
  12. Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. 2014. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8 Suppl 4 (Suppl 4): S11. https://doi.org/10.1186/1752-0509-8-S4-S11
  13. Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. 2017. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45 (W1): W98-w102. https://doi.org/10.1093/nar/gkx247
  14. Sunseri J, Koes DR. 2016. Pharmit: interactive exploration of chemical space. Nucleic Acids Res. 44 (W1): W442-448. https://doi.org/10.1093/nar/gkw287
  15. Trott O, Olson AJ. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31: 455-461. https://doi.org/10.1002/jcc.21334
  16. Burley SK, Bhikadiya C, Bi C, Bittrich S, Chen L, Crichlow GV, et al. 2021. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res. 49(D1): D437-d451. https://doi.org/10.1093/nar/gkaa1038
  17. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. 2009. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30: 2785-2791. https://doi.org/10.1002/jcc.21256
  18. Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, Roitberg AE. 2012. MMPBSA.py: an efficient program for end-state free energy calculations. J. Chem. Theory. Comput. 8: 3314-3321. https://doi.org/10.1021/ct300418h
  19. Fang B, Li Z, Qiu Y, Cho N, Yoo HM. 2021. Inhibition of UBA5 expression and induction of autophagy in breast cancer cells by usenamine A. Biomolecules 11: 1348. https://doi.org/10.3390/biom11091348
  20. Fang J, Ji WH, Wang FZ, Xie TM, Wang L, Fu ZF, et al. 2021. Circular RNA hsa_circ_0000700 promotes cell proliferation and migration in esophageal squamous cell carcinoma by sponging miR-1229. J. Cancer 12: 2610-2623. https://doi.org/10.7150/jca.47112
  21. Baiu I, Backhus L. 2020. Esophageal cancer surgery. JAMA 324: 1580. https://doi.org/10.1001/jama.2020.2101
  22. Fatehi Hassanabad A, Chehade R, Breadner D, Raphael J. 2020. Esophageal carcinoma: towards targeted therapies. Cell. Oncol. (Dordrecht). 43: 195-209. https://doi.org/10.1007/s13402-019-00488-2
  23. Tu Y, Chen L, Ren N, Li B, Wu Y, Rankin GO, et al. 2020. Standardized saponin extract from Baiye No.1 tea (Camellia sinensis) flowers induced S phase cell cycle arrest and apoptosis via AKT-MDM2-p53 signaling pathway in ovarian cancer cells. Molecules 25: 3515. https://doi.org/10.3390/molecules25153515
  24. Adelaide J, Monges G, Derderian C, Seitz JF, Birnbaum D. 1995. Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br. J. Cancer 71: 64-68. https://doi.org/10.1038/bjc.1995.13
  25. Schettini F, De Santo I, Rea CG, De Placido P, Formisano L, Giuliano M, et al. 2018. CDK 4/6 Inhibitors as single agent in advanced solid tumors. Front. Oncol. 8: 608. https://doi.org/10.3389/fonc.2018.00608
  26. Zhou J, Wu Z, Zhang Z, Goss L, McFarland J, Nagaraja A, et al. 2021. Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma. Gut 71: 665-675.
  27. Liu Z, Rader J, He S, Phung T, Thiele CJ. 2013. CASZ1 inhibits cell cycle progression in neuroblastoma by restoring pRb activity. Cell Cycle 12: 2210-2218. https://doi.org/10.4161/cc.25265
  28. Jin H, Zhang X, Su J, Teng Y, Ren H, Yang L. 2015. RNA interference-mediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells. Mol. Med. Rep. 12: 6617-6625. https://doi.org/10.3892/mmr.2015.4280
  29. Bendris N, Lemmers B, Blanchard JM, Arsic N. 2011. Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements. PLoS One 6: e22879. https://doi.org/10.1371/journal.pone.0022879
  30. Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, Massague J, et al. 1995. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376: 313-320. https://doi.org/10.1038/376313a0
  31. Lao-Sirieix P, Lovat L, Fitzgerald RC. 2007. Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance. Clin. Cancer Res. 13: 659-665. https://doi.org/10.1158/1078-0432.ccr-06-1385
  32. Waters AM, Asfahani R, Carroll P, Bicknell L, Lescai F, Bright A, et al. 2015. The kinetochore protein, CENPF, is mutated in human ciliopathy and microcephaly phenotypes. J. Med. Genet. 52: 147-156. https://doi.org/10.1136/jmedgenet-2014-102691
  33. Liu F, Fan Y, Ou L, Li T, Fan J, Duan L, et al. 2020. CircHIPK3 facilitates the G2/M transition in prostate cancer cells by sponging miR-338-3p. OncoTargets Ther. 13: 4545-4558. https://doi.org/10.2147/OTT.S242482
  34. Chen Z, Li HL, Zhang QJ, Bao XG, Yu KQ, Luo XM, et al. 2009. Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets. Acta pharmacol. Sin. 30: 1694-1708. https://doi.org/10.1038/aps.2009.159